Search research articles
Contact Us
Filters
Showing results (41-50 of 97) with videos related to
Page
of 10
Sort By:
Molecular Immunology
|
November 1, 1993
The 3' half of the mouse mammary tumor virus orf gene is not sufficient for its superantigen function in transgenic mice
J F Lambert, H Acha-Orbea, E Kolb, et al.
Seminars in Immunology
|
October 1, 1992
Infectious minor lymphocyte stimulating (Mls) antigens
H Acha-Orbea, G A Waanders, A N Shakhov, et al.
Immunity
|
October 2, 2002
CD4+CD3- cells induce Peyer's patch development: role of alpha4beta1 integrin activation by CXCR5
D Finke, H Acha-Orbea, A Mattis, et al.
International Immunology
|
September 1, 1994
MHC class II hierarchy of superantigen presentation predicts efficiency of infection with mouse mammary tumor virus
W Held, G A Waanders, H R MacDonald, et al.
Cell
|
June 2, 1989
T cell recognition as the target for immune intervention in autoimmune disease
D C Wraith, H O McDevitt, L Steinman, et al.
Nature
|
May 5, 1985
Identical V beta T-cell receptor genes used in alloreactive cytotoxic and antigen plus I-A specific helper T cells
F Rupp, H Acha-Orbea, H Hengartner, et al.
The EMBO Journal
|
December 1, 1990
Inhibition of lymphocyte mediated cytotoxicity by perforin antisense oligonucleotides
H Acha-Orbea, L Scarpellino, S Hertig, et al.
The Journal of Experimental Medicine
|
December 1, 1994
Reverse transcriptase-dependent and -independent phases of infection with mouse mammary tumor virus: implications for superantigen function
W Held, G A Waanders, H Acha-Orbea, et al.
The Journal of Experimental Medicine
|
October 1, 1994
Retroviral infection of neonatal Peyer's patch lymphocytes: the mouse mammary tumor virus model
O Karapetian, A N Shakhov, J P Kraehenbuhl, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1983
Characterization of cloned cytotoxic lymphocytes with NK-like activity
H Acha-Orbea, P Groscurth, R Lang, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 97) with videos related to
Sort By:
Page
of 10
Molecular Immunology
|
November 1, 1993
The 3' half of the mouse mammary tumor virus orf gene is not sufficient for its superantigen function in transgenic mice
J F Lambert, H Acha-Orbea, E Kolb, et al.
Seminars in Immunology
|
October 1, 1992
Infectious minor lymphocyte stimulating (Mls) antigens
H Acha-Orbea, G A Waanders, A N Shakhov, et al.
Immunity
|
October 2, 2002
CD4+CD3- cells induce Peyer's patch development: role of alpha4beta1 integrin activation by CXCR5
D Finke, H Acha-Orbea, A Mattis, et al.
International Immunology
|
September 1, 1994
MHC class II hierarchy of superantigen presentation predicts efficiency of infection with mouse mammary tumor virus
W Held, G A Waanders, H R MacDonald, et al.
Cell
|
June 2, 1989
T cell recognition as the target for immune intervention in autoimmune disease
D C Wraith, H O McDevitt, L Steinman, et al.
Nature
|
May 5, 1985
Identical V beta T-cell receptor genes used in alloreactive cytotoxic and antigen plus I-A specific helper T cells
F Rupp, H Acha-Orbea, H Hengartner, et al.
The EMBO Journal
|
December 1, 1990
Inhibition of lymphocyte mediated cytotoxicity by perforin antisense oligonucleotides
H Acha-Orbea, L Scarpellino, S Hertig, et al.
The Journal of Experimental Medicine
|
December 1, 1994
Reverse transcriptase-dependent and -independent phases of infection with mouse mammary tumor virus: implications for superantigen function
W Held, G A Waanders, H Acha-Orbea, et al.
The Journal of Experimental Medicine
|
October 1, 1994
Retroviral infection of neonatal Peyer's patch lymphocytes: the mouse mammary tumor virus model
O Karapetian, A N Shakhov, J P Kraehenbuhl, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1983
Characterization of cloned cytotoxic lymphocytes with NK-like activity
H Acha-Orbea, P Groscurth, R Lang, et al.
Page
of 10